|
SE352811B
(cg-RX-API-DMAC7.html)
|
1971-06-04 |
1973-01-15 |
Pharmacia Ab |
|
|
US3960150A
(en)
|
1971-09-09 |
1976-06-01 |
Alza Corporation |
Bioerodible ocular device
|
|
US3867519A
(en)
|
1972-04-27 |
1975-02-18 |
Alza Corp |
Bioerodible drug delivery device
|
|
SE375007B
(cg-RX-API-DMAC7.html)
|
1972-11-30 |
1975-04-07 |
Pharmacia Ab |
|
|
US3963025A
(en)
|
1974-09-16 |
1976-06-15 |
Alza Corporation |
Ocular drug delivery device
|
|
JPS5825980B2
(ja)
|
1976-02-12 |
1983-05-31 |
ヤマサ醤油株式会社 |
サイクリックヌクレオチドの定量法
|
|
US4186184A
(en)
|
1977-12-27 |
1980-01-29 |
Alza Corporation |
Selective administration of drug with ocular therapeutic system
|
|
US4303637A
(en)
|
1980-04-04 |
1981-12-01 |
Alza Corporation |
Medication indicated for ocular hypertension
|
|
DK231088D0
(da)
*
|
1988-04-28 |
1988-04-28 |
Ferrosan As |
Piperidinforbindelser, deres fremstilling og anvendelse
|
|
US5086063A
(en)
|
1988-03-28 |
1992-02-04 |
Du Pont Merck Pharmaceutical Company |
4-aryl-4-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
|
|
US5401629A
(en)
|
1990-08-07 |
1995-03-28 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Assay methods and compositions useful for measuring the transduction of an intracellular signal
|
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5869079A
(en)
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
HUP9902160A3
(en)
*
|
1996-03-29 |
2001-02-28 |
Pfizer |
Benzyl(idene)-lactam derivatives, their use as selective (ant)agonists of 5-ht1a-and/or 5-ht1d receptors, pharmaceutical compositions containing these compounds
|
|
JP2000513375A
(ja)
|
1996-06-28 |
2000-10-10 |
メルク エンド カンパニー インコーポレーテッド |
フィブリノーゲンレセプター拮抗薬プロドラッグ
|
|
JP4498602B2
(ja)
*
|
1998-03-10 |
2010-07-07 |
リサーチ・トライアングル・インスティチュート |
新規なオピエート化合物、その調製法及び使用法
|
|
AU1018801A
(en)
*
|
1999-10-29 |
2001-05-14 |
Novo Nordisk A/S |
Use of 3,4-substituted piperidines
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
CN100372850C
(zh)
*
|
2003-02-12 |
2008-03-05 |
神经研究公司 |
新的8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
|
|
SE0301445D0
(sv)
*
|
2003-05-16 |
2003-05-16 |
Astrazeneca Ab |
Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
|
|
JP2007507504A
(ja)
|
2003-09-30 |
2007-03-29 |
メルク エンド カムパニー インコーポレーテッド |
フェニルピロリジンエーテル系タキキニン受容体拮抗薬
|
|
DE602005023172D1
(de)
|
2004-07-16 |
2010-10-07 |
Schering Corp |
Hydantoinderivate zur behandlung von entzündlichen erkrankungen
|
|
US7488745B2
(en)
|
2004-07-16 |
2009-02-10 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
US7504424B2
(en)
|
2004-07-16 |
2009-03-17 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
US7098203B2
(en)
|
2004-07-20 |
2006-08-29 |
Bristol-Myers Squibb Company |
Homopiperidine derivatives as NK-1 antagonists
|
|
US7872023B2
(en)
|
2005-02-17 |
2011-01-18 |
Research Triangle Institute |
Kappa opioid receptor ligands
|
|
TW200804307A
(en)
|
2005-10-27 |
2008-01-16 |
Synta Pharmaceuticals Corp |
Process for preparing mesylate salts of IL-12 inhibitory compounds
|
|
CA2631221C
(en)
|
2005-12-01 |
2014-06-03 |
F. Hoffmann-La Roche Ag |
Serotonin transporter (sert) inhibitors
|
|
US20070142389A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Pfizer Inc. |
Piperidine derivatives
|
|
AU2007225208A1
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
|
US8470361B2
(en)
|
2006-12-04 |
2013-06-25 |
Orexo Ab |
Non-abusable pharmaceutical composition comprising opioids
|
|
KR20100017372A
(ko)
*
|
2007-05-25 |
2010-02-16 |
애보트 게엠베하 운트 콤파니 카게 |
향대사성 글루타메이트 수용체 2(mglu2 수용체)의 포지티브 조절자로서의 헤테로사이클릭 화합물
|
|
JP2010535733A
(ja)
|
2007-08-07 |
2010-11-25 |
エフ.ホフマン−ラ ロシュ アーゲー |
Nk3受容体アンタゴニストとしてのピロリジンアリールエーテル
|
|
EA201000808A1
(ru)
*
|
2007-11-16 |
2011-04-29 |
Ньюраксон, Инк. |
Индольные соединения и способы лечения висцеральной боли
|
|
US8664214B2
(en)
*
|
2010-03-30 |
2014-03-04 |
AbbVie Deutschland GmbH & Co. KG |
Small molecule potentiators of metabotropic glutamate receptors I
|
|
US8507535B2
(en)
|
2010-07-07 |
2013-08-13 |
Hoffmann-La Roche Inc. |
Methyl-pyrrolidine ether derivatives
|
|
ES2716865T3
(es)
*
|
2011-02-18 |
2019-06-17 |
Scripps Research Inst |
Diferenciación dirigida de células precursoras de oligodendrocitos a un destino celular mielinizante
|
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
ES2586213T3
(es)
*
|
2011-10-31 |
2016-10-13 |
Xenon Pharmaceuticals Inc. |
Compuestos de bencenosulfonamida y su uso como agentes terapéuticos
|
|
EP2810942B1
(en)
*
|
2012-01-31 |
2016-03-30 |
Eisai R&D Management Co., Ltd. |
Paroxetine derivative
|
|
WO2013182612A1
(en)
|
2012-06-07 |
2013-12-12 |
Bayer Pharma Aktiengesellschaft |
Glucose transport inhibitors
|
|
CA2896202A1
(en)
*
|
2012-12-28 |
2014-07-03 |
Purdue Pharma L.P. |
Substituted morphinans and the use thereof
|
|
WO2016029218A1
(en)
|
2014-08-22 |
2016-02-25 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Substituted 1-arylethyl-4-acylaminopiperidine derivatives as opioid/alpha-adrenoreceptor modulators and method of their preparation
|
|
WO2016210403A1
(en)
*
|
2015-06-26 |
2016-12-29 |
The Regents Of The University Of Michigan |
G protein-coupled receptor kinase inhibitors and methods for use of the same
|